Opposing actions of insulin and glucagon may be the key to glucose control.
Read More »When It’s Not a Good Idea to Recycle
Sometimes, just a simple instruction on the use of an insulin pen can prevent serious problems….
Read More »New One Minute Rapid-Acting Insulin: Lyumjev
Lyumjev, recently approved by the FDA, reaches the bloodstream only one minute after injection; how does its performance compare to Humalog?
Read More »Glucose-Lowering Medications and COVID-19 Outcomes in Patients with Diabetes
What factors and medications affect COVID-19 complications and mortality in patients with diabetes?
Read More »Oral Semaglutide + Basal Insulin
Analysis of the PIONEER 8 trial reveals dose-dependent reductions in A1c and body weight when oral semaglutide is paired with various insulin regimens.
Read More »Dealing with Difficult Patients
Ricardo, a 35-year-old man, newly diagnosed with type 1 diabetes, was hospitalized for diabetic ketoacidosis (DKA). Once he was stabilized, he wanted to go home. He refused to learn how to self-administer insulin. However, he was told he would not be discharged until he self-administered insulin, at least one time....
Read More »Exercising with Type 1 Diabetes: The Insulin-Food Balance Challenge
by Sheri Colberg, Ph.D., FACSM
Addressing how to balance blood glucose levels during (and after) exercise with type 1 diabetes is not new. In fact, it is likely the KEY topic to address to be successful at being physically active if you take exogenous insulin and want to prevent hypoglycemia or hyperglycemia during exercise. Strategies include changing in insulin doses and/or supplementing with food, either of which can be done in myriad ways depending on the activity, timing and more.
Once-Weekly Basal Insulin Shows Promise
Research into a new insulin analog with similar safety and efficacy as current long-acting insulins may help overcome clinical inertia.
Read More »Misunderstanding Basal Insulin Requirements Can Be Deadly
In an inpatient setting, a type 1 diabetes patient was scheduled for surgery the next morning. The patient was to be NPO after midnight and so the RN on duty withheld the patient's Lantus. The patient's glucose crept up, but this was not communicated....
Read More »New ADA Program Caps Medicare Insulin Co-Pays
American Diabetes Association® Secures Insulin Price Reductions for Seniors Through New CMS Senior Savings Model – New Program Will Cap Medicare Monthly Co-Pays at $35 ARLINGTON, Va. (May 26, 2020) – Today, the American Diabetes Association (ADA) joined the Centers for Medicare and Medicaid Services (CMS) for a White House event to announce the …
Read More »